Prevention of venous thromboembolism in surgical patients with breast cancer.
BACKGROUND
No randomized trial has yet studied venous thromboembolism (VTE) prophylaxis in patients undergoing surgery for breast cancer.


METHODS
Relevant articles were identified using Medline searches. Secondary articles were identified from the reference lists of key papers.


CONCLUSIONS
The absence of randomized trials comparing different methods of VTE prophylaxis with controls makes an evidence-based consensus among breast cancer surgeons difficult. Intermittent pneumatic compression (IPC) and graduated compression (GC) are effective in reducing VTE without the haemorrhagic complications associated with heparin; their effects are additive. The authors suggest the following strategy. All patients undergoing surgery for breast cancer should receive both IPC and GC, with heparin reserved for those at very high risk. A controlled trial should randomize women to receive heparin or not, and all women should have both IPC and GC. The primary endpoints should be the development of VTE and/or haemorrhagic complications.
Patiar
S
S
Department of Surgery, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK.
Kirwan
C C
CC
McDowell
G
G
Bundred
N J
NJ
McCollum
C N
CN
Byrne
G J
GJ
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001458:Bandages; D001943:Breast Neoplasms / Q000150:complications / Q000601:surgery*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D008408:Mastectomy / Q000009:adverse effects*; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight